Research: GAO and COLLEAGUES,

Listed in Issue 283

Abstract

GAO and COLLEAGUES, 1 College of Chemistry, Chemical Engineering and Materials Science, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Shandong Provincial Key Laboratory of Clean Production of Fine Chemicals, Shandong Normal University, Jinan 250014, P. R. China designed a pH sensitive multifunctional drug nanocarrier with controllable release of ascorbic acid under hypoxic environment to induce tumour cells' apoptosis via enhancing reductive stress, thereby dealing minimum damage to normal tissues.

Background

Destruction of the redox balance in tumour cells is of great significance for triggering their apoptosis in clinical applications. We designed a pH sensitive multifunctional drug nanocarrier with controllable release of ascorbic acid under hypoxic environment to induce tumour cells' apoptosis via enhancing reductive stress, thereby dealing minimum damage to normal tissues.

Methodology

A core-shell nanostructure of CdTe quantum dots with mesoporous silica coating was developed and functionalized with poly(2-vinylpyridine)-polyethylene glycol-folic acid, which achieves cancer cells' targeting delivery and reversibly pH controlled release of ascorbic acid both in vitro and in vivo.

Results

The result demonstrated that ascorbic acid can indeed lead liver cancer cells' death with the increase of nicotinamide adenine dinucleotide phosphate, while normal cells not being affected. The molecular mechanism of apoptosis induced by ascorbic acid was firstly elucidated at cellular levels, and further confirmed via in vivo investigations.

Conclusion

For the first time we proposed the concept for applying reductive stress into cancer treatments, which brings great advantage of toxicity free and less damage to normal tissues. In general, this technique has taken an important step in the development of a targeted tumour treatment system, providing perspectives for the design of medicines via reductive stress, and offers new insights into future clinical mild-therapies. Erratum: Gao X, Wei K, Hu B, Xu K, Tang B. Ascorbic acid induced HepG2 cells' apoptosis via intracellular reductive stress: Erratum. Theranostics. 1;11(4):1542. doi: 10.7150/thno.56023. eCollection 2021. Jan  2021.

References

Xiaonan Gao  1 , Keyan Wei  1 , Bo Hu  1 , Kehua Xu  1 , Bo Tang  1 . Ascorbic acid induced HepG2 cells' apoptosis via intracellular reductive stress. Theranostics;9 (14):4233-4240. doi: 10.7150/thno.33783. eCollection 2019. May 31 2019.

Comment

The above research demonstrates the clinical benefits of a multifunctional drug nanocarrier with controllable release of ascorbic acid under hypoxic environment to induce tumour cells' apoptosis.

ICAN Skyscraper

Scientific and Medical Network 2

Royal Rajasthan Cycle 2021

Amazon Wilderness Trek 2022

Cycle Kilimanjaro to the Coast 2022

top of the page